Welcome to IntelliGene Dx
My name is Bhakti Patel, and I am a Research & Development Consultant who collaborates closely with academic, biotechnology and biopharmaceutical partners to support innovation. I specialise in the use of molecular assays and Next Generation Sequencing (NGS) workflows in healthcare related fields.
With over 20 years' experience across academia and industry, I have deep expertise in genomics, molecular assay design, and the full range of NGS technologies across today's evolving landscape. Each technology, ranging from short- to ultra long-read sequencing, has a unique set of features, benefits, and scientific areas where the greatest potential lies.
I help clients navigate this field to address their scientific questions in the most impactful way. I create assays and workflows that are customised to each individual project and use the best matched technologies to generate high quality data, whilst balancing factors such as speed and cost. Projects span a variety of areas.
Targeted assays to investigate the cause of disease at a molecular level. Employ amplification-based assays to detect targets of interest, enhance workflows with NGS to generate sequence rich information.
Explore the latest NGS technologies for unlimited investigation of the human genome and/or epigenome. Elucidate the cause of rare or complex disease.
Use NGS to accelerate drug discovery. Achieve higher standards of quality control in the production of gene therapies and vaccines.
Highlight the advantages of new molecular biology and NGS tools by combining them with the right human health application or partner technology.
Expertise in genomic analysis
Inherited disease
Investigation of monogenic and complex disorders
Oncology
Germline and somatic cancer investigation
Immunogenetics
HLA typing
Reproductive genetics
Aneuploidy detection
Infectious disease
Detection of viruses/bacteria and determination of AMR
Portfolio
Optimisation of enzymatic DNA synthesis (EDS) technology for the SYNTAX system, a DNA printer that enables on-demand synthesis of custom DNA oligos in a benchtop solution.
Prototyping of clonal amplification methods to take place on the surface of a CMOS semiconductor chip, as a central component of the LiDia-SEQ platform, an end-to-end sequencing system designed for rapid point of need diagnostics.
.jpg){kind=logo}
CE-IVD assay development for the Enigma MiniLab platform, a real time PCR based system designed for point of care testing.
